FADD is upregulated in relapsing remitting multiple sclerosis

NeuroImmunoModulation

Volumn 21, Issue 5, 2014, Pages 221-225

  Reuss, Reinhard ^a,c   Mistarz, Marta ^c   Mirau, Andreas ^c   Kraus, Jörg ^e   Bödeker, Rolf Hasso ^d   Oschmann, Patrick ^b  

^a Department of Neurology Bezirkskrankenhaus Bayreuth ^*  (Germany)

^b Department of Neurology   (Germany)

^c Departments of Neurology   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

FADD protein; Multiple sclerosis; TRADD protein; Tumor necrosis factor receptor

Indexed keywords

FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN; RIP1 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; FADD PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GENE EXPRESSION; HUMAN; LEUKOCYTE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BLOOD; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CROSS-SECTIONAL STUDIES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TRANSCRIPTOME; UP-REGULATION;

EID: 84895643233     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000356522     Document Type: Article

References (22)

1. Farias AS, de la Hoz C, Castro FR, Oliveira EC, Ribeiro dos Reis JR, Silva JS, Langone F, Santos LMB: Nitric oxide and TNF-α effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation 2007; 14: 32-38. (Pubitemid 47340633)
2. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299-308. (Pubitemid 26042835)
3. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995; 81: 495-504.
4. Jiang Y, Woronicz JD, Liu W, Goeddel DV: Prevention of constitutive TNF receptor 1 signaling by silencer of death domain. Science 1999; 288: 543-546.
5. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV: TNF dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-396. (Pubitemid 26174054)
6. Micheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signalling complexes. Cell 2003; 114: 181-190. (Pubitemid 36936912)
7. Schneider-Brachert W, Tchikov V, Neumeyer I, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, Mentlein R, Kabelitz D, Schutze S: Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 2004; 21: 15-428.
8. Werner MH, Wu C, Walsh CM: Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle 2006; 5: 2332-2338. (Pubitemid 44785841)
9. Park SM, Schickel R, Peter ME: Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 2005; 17: 610-616. (Pubitemid 41540410)
10. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845-853. (Pubitemid 23270604)
11. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Pamryd I, Scheurich P, Schmid JA, Wajant H: Apoptotic crosstalk of TNF receptors: TNF-R2 induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 2002; 115: 2757-2770. (Pubitemid 34846516)
12. Bachmann R, Eugster HP, Frei K, Fontana A, Lassmann H: Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am J Pathol 1999; 154: 1417-1422. (Pubitemid 29226436)
13. Akassoglou K, Douni E, Bauer J, Lassmann H, Kollias G, Probert L: Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice. Proc Natl Acad Sci USA 2003; 100: 709-714. (Pubitemid 36126117)
14. Gomes AC, Jonsson G, Mjornheim S, Olsson T, Hillert J, Grandien A: Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis. J Neuroimmunol 2003; 135: 126-134. (Pubitemid 36170159)
15. Reuss R, Pohle S, Retzlaff K, Hemberger J, Oschmann P: Interferon β-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis. Neuroimmunomodulation 2009; 16: 171-176.
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
17. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452. (Pubitemid 14237132)
18. Kuhne BS, Oschmann P: Quantitative realtime RT-PCR using hybridization probes and imported standard curves for cytokine gene expression analysis. Biotechniques 2000; 33: 1078, 1080-1082, 1084.
19. Lenercept Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group: TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999; 53: 457-465.
20. Reuss R, Mirau A, Mistarz M, Kraus J, Bodeker RH, Oschmann P: TRAF2 is upregulated in relapsing remitting multiple sclerosis. Neuroimmunomodulation 2013; 20: 177-183.
21. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti C, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H: The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-1189.
22. Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD: Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell Immunol 2000; 205: 24-33.